Detailed answers about GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED founded?
GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED was officially incorporated on 14 May 2020 and is registered under company number 12602039. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED?
GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED do?
GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED's registered address?
The registered office address of GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED is 12 EAKER STREET, HIGH WYCOMBE, UNITED KINGDOM, HP11 1BF. This is the official address filed with Companies House for legal and statutory correspondence.
Is GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED financially stable?
The most recent accounts for GLOBAL RADIOLOGY AND MEDICAL SOLUTIONS LIMITED were made up to 31 May 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 28 February 2027.